glp 1 blood brain barrier Beyond diabetes and obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation - Spezani - 2026 - Diabetes, Obesity and Metabolism Frontiers | Brain Endothelial Cells

Crystal structures of pertussis toxin with NAD(+) and analogs provide structural insights into the mechanism of its cytosolic ADP-ribosylation activity

First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations

It is often marketed as a fat-loss peptide because preclinical research suggests that it may influence the breakdown and storage of fat without producing all the effects associated with full-length growth hormone

So its been going on for a while

All three are indexed on PubMed for full-text review

The outcome is not trend-driven but scientific, safe, and natural